contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


first-patients-treated-with-corethermr-concept-in-austria

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

ProstaLund är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning, utveckling och vidare behandling av prostataförstoring (BPH). Via bolagets CoreTherm ges värmebehandling av godartad prostataförstoring, utan behov av ett kirurgiskt ingrepp. Visionen är att erbjuda alternativa lösningar gentemot traditionella tillvägagångssätt. Bolaget grundades ursprungligen under 1991 och har verksamhet på global nivå, med huvudkontoret i Lund.

ProstaLund

We are pleased to announce that the first five patients with benign prostatic enlargement (BPE) have been successfully treated with the CoreTherm® Concept in Austria. The treatments were performed...

<div class="mfn-preamble"><p><strong>We are pleased to announce that the first five patients with benign prostatic enlargement (BPE) have been successfully treated with the CoreTherm® Concept in Austria. The treatments were performed by MR Prof. Dr. Karl Diehl in Tulln an der Donau.</strong></p></div><div class="mfn-body"><p>“We signed the agreement with Prof. Dr. Karl Diehl in May 2024, and it is fantastic news that the first patients have now been successfully treated. This marks an important first step in establishing CoreTherm® in Europe, fully in line with the company’s stated strategy” said Anders Kristensson, CEO of ProstaLund AB.</p></div><div class="mfn-footer mfn-43458186cf95"><p><strong class="mfn-heading-1">For further information, please contact:</strong></p><hr><p>Anders Kristensson,&nbsp;CEO<br>Tel. +46 (0) 769 42 12 16<br>Email: anders.kristensson@prostalund.com</p></div><div class="mfn-footer mfn-3ac97e60f473"><p><strong class="mfn-heading-1">About CoreTherm®</strong></p><hr><p>CoreTherm® is a minimally invasive transurethral microwave thermotherapy for benign prostatic enlargement (BPE). The treatment is performed in an outpatient setting under local anaesthesia and takes less than 15 minutes. No general anaesthesia or spinal block is needed. Follow-up data five years after CoreTherm® treatment shows clinical outcomes comparable to those seen after surgery/TURP (transurethral resection of the prostate), but with lower risk of serious complications. For more information visit, <a rel="noopener" href="http://www.coretherm.com">www.coretherm.com</a>.</p></div><div class="mfn-footer mfn-about mfn-6fe429febaf6"><p><strong class="mfn-heading-1">About ProstaLund</strong></p><hr><p>ProstaLund AB (publ) is a Swedish medtech company headquartered in Lund that develops and markets innovative products for the treatment of Benign Prostatic Enlargement (BPE). The company has patented the CoreTherm® Concept, a customised thermal treatment for BPE. ProstaLund is listed on Nasdaq First North Growth Market and has approximately 3,600 shareholders. For more information, visit <a rel="noopener" href="http://www.prostalund.se">www.prostalund.se</a>. Our press releases are also available to read and download here: <a rel="noopener" href="http://www.prostalund.se/pressmeddelanden">www.prostalund.se/pressmeddelanden</a></p><p><strong>Certified Adviser</strong>:<br>Västra Hamnen Corporate Finance AB<br>Phone: +46 40 200 250<br>E-mail: <a rel="noopener" href="mailto:ca@vhcorp.se">ca@vhcorp.se</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/36613c42-c91c-4061-8105-a2b3e22ed96b/first-patients-treated-with-coretherm-r-concept-in-austria.pdf" class="mfn-generated mfn-primary">First patients treated with CoreTherm® Concept in Austria</a></p></div>

Beställ vårt nyhetsbrev — inget användarkonto krävs!